176 related articles for article (PubMed ID: 22051450)
1. Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD.
Verhamme KM; Afonso AS; van Noord C; Haag MD; Koudstaal PJ; Brusselle GG; Sturkenboom MC
Pulm Pharmacol Ther; 2012 Feb; 25(1):19-26. PubMed ID: 22051450
[TBL] [Abstract][Full Text] [Related]
2. Tiotropium Respimat inhaler and the risk of death in COPD.
Wise RA; Anzueto A; Cotton D; Dahl R; Devins T; Disse B; Dusser D; Joseph E; Kattenbeck S; Koenen-Bergmann M; Pledger G; Calverley P;
N Engl J Med; 2013 Oct; 369(16):1491-501. PubMed ID: 23992515
[TBL] [Abstract][Full Text] [Related]
3. Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD.
Verhamme KM; Afonso A; Romio S; Stricker BC; Brusselle GG; Sturkenboom MC
Eur Respir J; 2013 Sep; 42(3):606-15. PubMed ID: 23520322
[TBL] [Abstract][Full Text] [Related]
4. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
5. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: are they equivalent?
Mathioudakis AG; Chatzimavridou-Grigoriadou V; Evangelopoulou E; Mathioudakis GA; Siafakas NM
Pulm Pharmacol Ther; 2014 Aug; 28(2):91-7. PubMed ID: 24846455
[TBL] [Abstract][Full Text] [Related]
6. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Singh S; Loke YK; Enright P; Furberg CD
Postgrad Med J; 2014 Apr; 90(1062):205-7. PubMed ID: 24643260
[TBL] [Abstract][Full Text] [Related]
7. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
Gershon AS; Wang L; To T; Luo J; Upshur RE
COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
[TBL] [Abstract][Full Text] [Related]
8. Inhaled anticholinergic drugs and risk of acute urinary retention.
Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
[TBL] [Abstract][Full Text] [Related]
9. Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database.
Jara M; Lanes SF; Wentworth C; May C; Kesten S
Drug Saf; 2007; 30(12):1151-60. PubMed ID: 18035867
[TBL] [Abstract][Full Text] [Related]
10. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
[TBL] [Abstract][Full Text] [Related]
11. Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD.
Worth H; Chung KF; Felser JM; Hu H; Rueegg P
Respir Med; 2011 Apr; 105(4):571-9. PubMed ID: 21227674
[TBL] [Abstract][Full Text] [Related]
12. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
[TBL] [Abstract][Full Text] [Related]
13. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications.
Singh S; Loke YK; Enright P; Furberg CD
Thorax; 2013 Jan; 68(1):114-6. PubMed ID: 22764216
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of tiotropium bromide (spiriva) in the treatment of patients with chronic obstructive pulmonary disease of varying severity: results of the Russian trial].
Stepanian IE; Khmel'kova NG; Belin-Atarac B
Ter Arkh; 2010; 82(10):46-51. PubMed ID: 21341464
[TBL] [Abstract][Full Text] [Related]
17. Comparative Cardiovascular and Cerebrovascular Safety of Inhaled Long-Acting Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study.
Dong YH; Chang CH; Gagne JJ; Hsu CL; Lai MS
Pharmacotherapy; 2016 Jan; 36(1):26-37. PubMed ID: 26799347
[TBL] [Abstract][Full Text] [Related]
18. Tiotropium Respimat increases the risk of mortality.
Jenkins CR; Beasley R
Thorax; 2013 Jan; 68(1):5-7. PubMed ID: 23229813
[No Abstract] [Full Text] [Related]
19. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
Cyr MC; Beauchesne MF; Lemière C; Aaron SD; Blais L
Ann Pharmacother; 2010 Apr; 44(4):613-22. PubMed ID: 20233915
[TBL] [Abstract][Full Text] [Related]
20. Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial.
Tashkin DP; Leimer I; Metzdorf N; Decramer M
Respir Res; 2015 Jun; 16(1):65. PubMed ID: 26031308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]